Facebook’s (NASDAQ:FB) log in rates remain steady but posting rates decline, Pacific Crest claims. According to the firm, 27% of respondents have been posting less while only 12% have been posting more. The firm keeps a Sector Perform rating and a price target of $25 on the stock.
WellCare Health Plans, Inc. (NYSE:WCG) is the next most likely plan by Medicaid which will be acquired after Wellpoint’s (NYSE:WLP) takeover of Amerigroup (NYSE:AGP), according to Wedbush, who also believes this company would be a great strategic fit for Aetna (NYSE:AET). Wedbush calculates a possible Wellcare acquisition price in the range on $79-$101 per share. The firm also expects Centene’s (NYSE:CNC) acquisition will be $46-$68 per share and Molina Healthcare (NYSE:MOH) will be at $44-$65 per share.
Luminex Corporation (NASDAQ:LMNX) target has been lowered by Piper Jaffray following the LA Times publishing of an article which the firm views as raising questions regarding the Luminex BioWatch’s ability to quickly detect dangerous pathogens, which is its main purpose. Currently, the firm sees total implementation of the BioWatch program as uncertain, and the firm keeps its Underweight rating on the stock.
Southwest Airlines Co. (NYSE:LUV) Q2 passenger revenue per available seat mile forecasts have been increased by Imperial Capital following the company’s report of its traffic figures for June, but the firm still does not view the large projects of the company as a possible earning impact until around 2013 or later.
Allergan Inc. (NYSE:AGN): Wells Fargo states that according to ImpactRx data, Allergan’s Botox for migraine market share reached its highest in history during June, 9.0% compared to May’s 8.7%. On the other hand, Wells states that the non-migraine market share for Botox dropped to 28% in June from May’s 32%. The firm maintains its Outperform rating on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.